EMEA-001501-PIP04-19-M01

Table of contents

Key facts

Invented name
Dupixent
Active substance
dupilumab
Therapeutic area
Gastroentology-Hepatology
Decision number
P/0361/2021
PIP number
EMEA-001501-PIP04-19-M01
Pharmaceutical form(s)
Solution for injection
Condition(s) / indication(s)
Treatment of eosinophilic esophagitis
Route(s) of administration
Subcutaneous use
Contact for public enquiries
Regeneron Ireland DAC

Tel. +1 9148 475385
E-mail: clinicaltrials@regeneron.com

Decision type
PM: decision on the application for modification of an agreed PIP

Decision

Related content

How useful was this page?

Add your rating